Eledon Pharmaceuticals
Manufacturing · California, United States · 11-50 Employees
View Company Info for Free
Overview
Headquarters
19800 Macarthur Blvd Ste 250, Irvine, Ca...Phone Number
(949) 238-8090Website
www.eledon.comRevenue
-Stock Symbol
ELDNIndustry
ZI Rank: 1
Signal Type
Jan
Feb
Mar
Apr
May
Jun
ZI Rank
2
1
1
1
1
1
About Eledon Pharmaceuticals
Founded in 2020, Eledon Pharmaceuticals is a clinical stage biotechnology company using its expertise in targeting the CD40 Ligand (CD40L, also called CD154) pathway to develop potential treatments for persons requiring an organ or cell-based transplant, living with autoimmune disease, or living with ALS.Explore more
Eledon Pharmaceuticals Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is Eledon Pharmaceuticals your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Website visits: Recent activity has been detected on your website
Eledon Pharmaceuticals, which may be a good buyer, showed buying intent in Masked Content Topic
Congratulate Masked Content for being promoted to Masked Content at Eledon Pharmaceuticals
Click to see if Eledon Pharmaceuticals had a recent Job posting/layoffs
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Funding: Get notified immidiatlly once Eledon Pharmaceuticals has new funding data
Earning: See what the market has to say on Eledon Pharmaceuticals recently announced quarterly report
Check if Eledon Pharmaceuticals has recently received funding, and reach out quickly before it becomes old news!
Check out if Eledon Pharmaceuticals is spiking on competitors!
Product Launch: Get notified when Eledon Pharmaceuticals launches new products
Recommended Actions
Reach out to Masked Content who joined Eledon Pharmaceuticals as Masked Content
Find more new buyers
Compare Similar Companies to Eledon Pharmaceuticals
Compare insights from companies similar to Eledon Pharmaceuticals, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Company Profile Activity
Activity Insights
Eledon Pharmaceuticals is experiencing very low activity levels compared to other companies in the Manufacturing sector.
What does this means?
Eledon Pharmaceuticals is drawing exceptional interest within the Manufacturing industry, suggesting notable developments or strong market momentum, learn more about Eledon Pharmaceuticals.
Eledon Pharmaceuticals Tech Stack
A closer look at the technologies used by Eledon Pharmaceuticals
See more technologies
Most Recent Scoops
Project
Eledon Pharmaceuticals has progressed its subcutaneous formulation of tegoprubart, having already completed a healthy volunteer study, with plans to begin testing this formulation in transplant patients early next year.
Pharmaceuticals, Clinical Operations
Project
Eledon Pharmaceuticals has reported that 96% of patients in the Phase II BESTOW study elected to remain on tegoprubart in the long-term extension at the end of 52 weeks, rather than switching to tacrolimus.
Pharmaceuticals, Clinical Operations
Project
Eledon Pharmaceuticals has reported no graft loss in either arm of the Phase II BESTOW study, no cases of PML or PTLD in either arm, and noted that approximately 200 patients have been exposed to tegoprubart to date with no PML or PTLD observed.
Medical Research
Project
Eledon Pharmaceuticals has begun clinical trials for a new indication in kidney transplant tolerance induction, conducted as an investigator-sponsored trial at Massachusetts General Hospital in Boston, with two patients already transplanted.
Medical Research, Clinical Operations
Project
Research & Development, Pharmaceuticals
Eledon Pharmaceuticals News & Media
Eledon Presents Long-Term Extension Phase 2 BESTOW Results at American Transplant Congress Showing Sustained Higher Kidney Function and Improved Patient-Reported Outcomes with Tegoprubart Compared with Tacrolimus
Eledon Presents Long-Term Phase 2 BESTOW Results at ATC Showing Sustained Higher Kidney Function and Improved Patient-Reported Outcomes with TegoprubartEledon Announces Updated Data from Investigator-Initiated Islet Transplant Trial of Tegoprubart in Patients with Type 1 Diabetes (T1D) at UChicago Medicine
Eledon Announces Updated Data from Investigator-Initiated Islet Transplant Trial of Tegoprubart in Patients with Type 1 Diabetes (T1D) at UChicago MedicineEledon Announces Presentation of Updated Data from Investigator-Initiated Islet Transplant Trial of Tegoprubart in Patients with Type 1 Diabetes at American Diabetes Association (ADA) 2026 Scientific Sessions
Eledon Announces Presentation of Updated Data from Investigator-Initiated Islet Transplant Trial of Tegoprubart in Patients with Type 1 Diabetes at ADAEledon Pharmaceuticals to Present New Long-Term Data from Phase 2 BESTOW Trial of Tegoprubart for the Prevention of Rejection in Kidney Transplantation at American Transplant Congress
Eledon to Present New Long-Term Data from Phase 2 BESTOW Trial of Tegoprubart for the Prevention of Rejection in Kidney Transplantation at ATC
Read more news
Top Manufacturing Companies
Top companies in Canada by revenue
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Eledon Pharmaceuticals
Sign Up For FreeTo access detailed company insights
Founded in 2020, Eledon Pharmaceuticals is a clinical stage biotechnology company using its expertise in targeting the CD40 Ligand (CD40L, also called CD154) pathway to develop potential treatments for persons requiring an organ or cell-based transplant, living with autoimmune disease, or living with ALS.... Read More
